Speaker illustration

Doctor Ofri Mosenzon

The Hebrew University of Jerusalem, Jerusalem (Israel)

ESC Webinars Series - Diabetes. Focus on SGLT2 Inhibitors - New data and guidelines change practice

25 February 2020, from 18:00 to 19:00 CET
Thumbnail

This platform is supported by

logo Novo Nordisk